Pharmacology, Toxicology and Pharmaceutical Science
Prevalence
100%
Cardiovascular Risk
100%
Thrombosis
100%
Hypercholesterolemia
100%
Disease
50%
Syndrome
50%
Coronary Artery Disease
50%
Antithrombocytic Agent
50%
Obesity
50%
Cardiovascular Disease
50%
Antihypertensive Agent
50%
Cerebrovascular Disease
50%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
50%
Peripheral Occlusive Artery Disease
50%
Beta Adrenergic Receptor Blocking Agent
50%
Dipeptidyl Carboxypeptidase Inhibitor
50%
Atherosclerosis
50%
Angiotensin Receptor Antagonist
50%
Medicine and Dentistry
Cardiovascular Risk
100%
Thrombosis
100%
Outpatient
100%
Prevalence
66%
Hypercholesterolemia
66%
Disease
33%
Drug Therapy
33%
Clinical Syndrome
33%
Coronary Artery Disease
33%
Cardiovascular System
33%
Cardiovascular Disease
33%
Obesity
33%
Atherosclerosis
33%
Antihypertensive Agent
33%
Statin
33%
Arteriosclerosis Obliterans
33%
Beta Adrenergic Receptor Blocking Agent
33%
Smoking
33%
Antiplatelet Drug
33%
ACE Inhibitor
33%
Patient with Hypertension
33%
Angiotensin Receptor Antagonist
33%
Cerebrovascular Disease
33%
Keyphrases
Israel
100%
Israeli
100%
Cardiovascular Risk
100%
Atherothrombosis
100%
Prevelance
100%
Hypercholesterolemia
28%
Risk Factors
14%
Obesity
14%
Clinical Syndromes
14%
Coronary Artery Disease
14%
High Prevalence
14%
Cardiovascular Disease
14%
Antiplatelet Agents
14%
Most Common Cause
14%
Atherosclerotic Risk Factors
14%
Statins
14%
Cause of Death
14%
Cardiovascular Morbidity
14%
Cerebrovascular Disease
14%
Peripheral Arterial Disease
14%
Beta-blockers
14%
International Registry
14%
Angiotensin-converting Enzyme Inhibitor (ACEi)
14%
Industrialized World
14%
Patients with Hypertension
14%
Angiotensin Receptor Blockers
14%
Atherothrombotic Disease
14%
Former Smokers
14%
International Control
14%
Biochemistry, Genetics and Molecular Biology
Prevalence
100%
Hypercholesterolemia
100%
Enzyme Inhibitor
50%
Statin
50%
Smoking
50%
Angiotensin-Converting Enzyme
50%
Angiotensin Receptor
50%
Beta Blocker
50%